362 related articles for article (PubMed ID: 9349228)
1. Quality assessment by expert opinion in melanoma pathology: experience of the pathology panel of the Dutch Melanoma Working Party.
Veenhuizen KC; De Wit PE; Mooi WJ; Scheffer E; Verbeek AL; Ruiter DJ
J Pathol; 1997 Jul; 182(3):266-72. PubMed ID: 9349228
[TBL] [Abstract][Full Text] [Related]
2. Expert review remains important in the histopathological diagnosis of cutaneous melanocytic lesions.
van Dijk MC; Aben KK; van Hees F; Klaasen A; Blokx WA; Kiemeney LA; Ruiter DJ
Histopathology; 2008 Jan; 52(2):139-46. PubMed ID: 18184263
[TBL] [Abstract][Full Text] [Related]
3. Genetic and epigenetic alterations in the differential diagnosis of malignant melanoma and spitzoid lesion.
Takata M; Lin J; Takayanagi S; Suzuki T; Ansai S; Kimura T; Cerroni L; Saida T
Br J Dermatol; 2007 Jun; 156(6):1287-94. PubMed ID: 17535228
[TBL] [Abstract][Full Text] [Related]
4. DNA in situ hybridization as a diagnostic tool in the discrimination of melanoma and Spitz naevus.
De Wit PE; Kerstens HM; Poddighe PJ; Van Muijen GN; Ruiter DJ
J Pathol; 1994 Jul; 173(3):227-33. PubMed ID: 7931843
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic discord with melanoma.
Cook MG
J Pathol; 1997 Jul; 182(3):247-9. PubMed ID: 9349225
[TBL] [Abstract][Full Text] [Related]
6. [Comparative study of HMB-45 monoclonal antibody uptake on various benign and malignant melanocytic lesions].
Lampert A; Thomine E; Lauret P; Hemet J
Ann Pathol; 1993; 13(2):100-7. PubMed ID: 8363667
[TBL] [Abstract][Full Text] [Related]
7. [Three patients with a Spitz naevus that later turned out to be a melanoma].
Bron JL; Jaspars EH; Molenkamp BG; Meijer S; Mooi WJ; van Leeuwen PA
Ned Tijdschr Geneeskd; 2005 Aug; 149(33):1852-8. PubMed ID: 16128184
[TBL] [Abstract][Full Text] [Related]
8. Combined naevus: a benign lesion frequently misdiagnosed both clinically and pathologically as melanoma.
Scolyer RA; Zhuang L; Palmer AA; Thompson JF; McCarthy SW
Pathology; 2004 Oct; 36(5):419-27. PubMed ID: 15370111
[TBL] [Abstract][Full Text] [Related]
9. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
Nasr MR; El-Zammar O
Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
[TBL] [Abstract][Full Text] [Related]
10. Discordance in the histopathologic diagnosis of melanoma at a melanoma referral center.
Shoo BA; Sagebiel RW; Kashani-Sabet M
J Am Acad Dermatol; 2010 May; 62(5):751-6. PubMed ID: 20303612
[TBL] [Abstract][Full Text] [Related]
11. A fluorescence in situ hybridization (FISH) procedure to assist in differentiating benign from malignant melanocytic lesions.
Clemente C; Bettio D; Venci A; Scopsi L; Rao S; Ferrari A; Piris A; Mihm MC
Pathologica; 2009 Oct; 101(5):169-74. PubMed ID: 20218056
[TBL] [Abstract][Full Text] [Related]
12. Nodular lesions arising in a large congenital melanocytic naevus in a newborn with eruptive disseminated Spitz naevi.
Feito-Rodríguez M; de Lucas-Laguna R; Bastian BC; Leboit P; González-Beato MJ; López-Gutiérrez JC; Requena L; Pizarro A
Br J Dermatol; 2011 Nov; 165(5):1138-42. PubMed ID: 21711345
[TBL] [Abstract][Full Text] [Related]
13. Surveillance of patients at high risk for cutaneous malignant melanoma using digital dermoscopy.
Bauer J; Blum A; Strohhäcker U; Garbe C
Br J Dermatol; 2005 Jan; 152(1):87-92. PubMed ID: 15656806
[TBL] [Abstract][Full Text] [Related]
14. Current diagnostic problems in melanoma pathology.
Ruiter DJ; van Dijk MC; Ferrier CM
Semin Cutan Med Surg; 2003 Mar; 22(1):33-41. PubMed ID: 12773012
[TBL] [Abstract][Full Text] [Related]
15. Significant melanocytic lesions in infancy, childhood, and adolescence.
Hoss DM; Grant-Kels JM
Dermatol Clin; 1986 Jan; 4(1):29-44. PubMed ID: 3521978
[TBL] [Abstract][Full Text] [Related]
16. Allelic imbalance in the diagnosis of benign, atypical and malignant Spitz tumours.
van Dijk MC; Rombout PD; Mooi WJ; van de Molengraft FJ; van Krieken JH; Ruiter DJ; Ligtenberg MJ
J Pathol; 2002 Jun; 197(2):170-8. PubMed ID: 12015740
[TBL] [Abstract][Full Text] [Related]
17. The approach to the patient with a difficult melanocytic lesion.
Elder DE; Xu X
Pathology; 2004 Oct; 36(5):428-34. PubMed ID: 15370112
[TBL] [Abstract][Full Text] [Related]
18. Integrating clinical/dermatoscopic findings and fluorescence in situ hybridization in diagnosing melanocytic neoplasms with less than definitive histopathologic features.
Nardone B; Martini M; Busam K; Marghoob A; West DP; Gerami P
J Am Acad Dermatol; 2012 Jun; 66(6):917-22. PubMed ID: 21962759
[TBL] [Abstract][Full Text] [Related]
19. WT1 as a complementary marker of malignant melanoma: an immunohistochemical study of whole sections.
Wilsher M; Cheerala B
Histopathology; 2007 Nov; 51(5):605-10. PubMed ID: 17927581
[TBL] [Abstract][Full Text] [Related]
20. Malignant melanoma in childhood.
Handfield-Jones SE; Smith NP
Br J Dermatol; 1996 Apr; 134(4):607-16. PubMed ID: 8733359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
